C4 THERAPEUTICS INC (CCCC) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:CCCC • US12529R1077

1.9 USD
-0.06 (-3.06%)
At close: Jan 30, 2026
1.89 USD
-0.01 (-0.53%)
After Hours: 1/30/2026, 6:38:23 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
CCCC revenue by date.CCCC revenue by date.
31.1M
-32.08%
20.756M
-33.26%
35.584M
71.44%
31.785M
-10.68%
22.979M
-27.70%
23.409M
1.87%
139.19M
494.60%
1.073B
670.89%
3.056B
184.81%
324.39M
-89.39%
489.22M
50.81%
729.93M
49.20%
EBITDA
YoY % growth
CCCC ebitda by date.CCCC ebitda by date.
-127.85M
-58.54%
-137.151M
-7.27%
-115.359M
15.89%
-118.32M
-2.57%
-137.7M
-16.38%
-178.5M
-29.63%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
CCCC ebit by date.CCCC ebit by date.
-129.53M
-57.71%
-139.031M
-7.33%
-117.177M
15.72%
-126.781M
-8.20%
-151.945M
-19.85%
-159.477M
-4.96%
-108.292M
32.10%
207.72M
291.82%
1.118B
438.22%
44.875M
-95.99%
242.84M
441.15%
427.97M
76.24%
Operating Margin
CCCC operating margin by date.CCCC operating margin by date.
-416.50%-669.84%-329.30%-398.87%-661.24%-681.26%-77.80%19.36%36.58%13.83%49.64%58.63%
EPS
YoY % growth
CCCC eps by date.CCCC eps by date.
-2.63
-44.51%
-2.66
-1.14%
-1.51
43.23%
-1.47
2.83%
-1.34
8.76%
-1.22
8.90%
0.09
107.11%
3.28
3,680.35%
13.48
311.21%
0.87
-93.57%
2.81
223.53%
4.23
50.91%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.31
36.78%
-0.31
16.33%
-0.32
13.16%
-0.35
21.12%
-0.39
-27.01%
Revenue
Q2Q % growth
6.589M
27.27%
3.4M
-53.03%
3.4M
-47.39%
3.4M
-69.72%
3.4M
-48.40%
EBITDA
Q2Q % growth
-36.261M
-1.03%
N/AN/AN/AN/A
EBIT
Q2Q % growth
-35.562M
5.69%
-37.4M
-28.24%
-40.46M
-41.96%
-43.86M
-85.23%
-46.92M
-31.94%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.44
-25.71%
-0.41-0.03-6.21%
Q2 2025
Q2Q % growth
-0.37
-42.31%
-0.390.025.54%
Q1 2025
Q2Q % growth
-0.37
9.76%
-0.460.0919.39%
Q4 2024
Q2Q % growth
-0.49
30.00%
-0.490.00-0.55%
Q3 2024
Q2Q % growth
-0.35
32.69%
-0.390.049.70%
Q2 2024
Q2Q % growth
-0.26
64.38%
-0.380.1231.42%
Q1 2024
Q2Q % growth
-0.41
42.25%
-0.36-0.05-14.38%
Q4 2023
Q2Q % growth
-0.70
9.09%
-0.700.00-0.55%
Q3 2023
Q2Q % growth
-0.52
20.00%
-0.670.1522.76%
Q2 2023
Q2Q % growth
-0.73
-30.36%
-0.70-0.03-4.06%
Q1 2023
Q2Q % growth
-0.71
-9.23%
-0.760.056.66%
Q4 2022
Q2Q % growth
-0.77
-148.39%
-0.76-0.01-1.50%
Q3 2022
Q2Q % growth
-0.65
-27.45%
-0.680.034.89%
Q2 2022
Q2Q % growth
-0.56
-9.80%
-0.710.1520.76%
Q1 2022
Q2Q % growth
-0.65
-32.65%
-0.59-0.06-10.14%
Q4 2021
Q2Q % growth
-0.31
-675.00%
-0.590.2847.82%
Q3 2021
Q2Q % growth
-0.51
97.09%
-0.600.0915.49%
Q2 2021
Q2Q % growth
-0.51 -0.600.0915.25%
Q1 2021
Q2Q % growth
-0.49 -0.640.1523.75%
Q4 2020
Q2Q % growth
-0.04 -0.540.5092.60%
Q3 2020
Q2Q % growth
-17.55 -0.81-16.74-2,077.96%
CCCC Yearly EPS VS EstimatesCCCC Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 -5 10 -10
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
11.23M
-26.90%
6.406M4.824M75.30%
Q2 2025
Q2Q % growth
6.463M
-46.17%
6.681M-218K-3.26%
Q1 2025
Q2Q % growth
7.238M
138.17%
4.539M2.699M59.46%
Q4 2024
Q2Q % growth
5.177M
58.75%
5.228M-51K-0.98%
Q3 2024
Q2Q % growth
15.362M
38.75%
4.692M10.67M227.41%
Q2 2024
Q2Q % growth
12.006M
350.68%
4.879M7.127M146.08%
Q1 2024
Q2Q % growth
3.039M
-19.15%
8.262M-5.223M-63.22%
Q4 2023
Q2Q % growth
3.261M
14.42%
3.253M8K0.25%
Q3 2023
Q2Q % growth
11.072M
64.03%
5.569M5.503M98.81%
Q2 2023
Q2Q % growth
2.664M
-80.74%
6.568M-3.904M-59.44%
Q1 2023
Q2Q % growth
3.759M
-50.86%
5.572M-1.813M-32.54%
Q4 2022
Q2Q % growth
2.85M
-85.81%
7.969M-5.119M-64.24%
Q3 2022
Q2Q % growth
6.75M
-20.59%
9.253M-2.503M-27.05%
Q2 2022
Q2Q % growth
13.83M
41.41%
7.79M6.04M77.54%
Q1 2022
Q2Q % growth
7.65M
2.96%
8.211M-561K-6.83%
Q4 2021
Q2Q % growth
20.08M
143.10%
7.226M12.854M177.89%
Q3 2021
Q2Q % growth
8.5M
0.59%
7.759M741K9.55%
Q2 2021
Q2Q % growth
9.78M
-40.68%
6.137M3.643M59.36%
Q1 2021
Q2Q % growth
7.43M 3.942M3.488M88.48%
Q4 2020
Q2Q % growth
8.26M 8.16M100K1.23%
Q3 2020
Q2Q % growth
8.45M 5.202M3.248M62.44%
CCCC Yearly Revenue VS EstimatesCCCC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 1B 2B 3B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 17.95% 7.45% 7.27%
Revenue0% -0.32% 0% 15.5%